Monivent AB is developing a product to improve treatment of newborns in need of ventilation at birth. 3-6% of the newborns need help in order to start breathing and air is manually forced down the babies’ lungs.

Sub-optimal treatment may contribute to serious damage to lungs and other organs. Monivent Neo measure the airflow through a sensor and data is sent to an external monitor which allows the caregiver to make the necessary adjustments to achieve a more effective and gentle treatment.